Bipolar Disorder and Diabetes Mellitus: Epidemiology, Etiology, and Treatment Implications

References

• Akiskal HS, Bourgeois ML, Angst, J, Post R, Moller, H, and Hirschfeld R: Re-Evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disor-ders.J Affect. Disord. 2000; 59 Suppl 1:S5–S30
   Google Scholar
• Judd LL and Akiskal HS: The prevalence and disability of bipolar spectrum disorders in the US population: Re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Disord. 2003; 73(1–2):123–131
   Google Scholar
• Tohen M, Strakowski SM, Zarate C Jr., Hennen J, Stoll A.L, Suppes T, Faedda GL, Cohen BM, Gebre-Medhin P, and Cohen BM :Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am. J. Psychiatry 2000; 157(2):220–228
   Google Scholar
• Wyatt RJ and Henter I: An economic evaluation of manic-depres-sive illness-1991. Soc. Psychiatry. Psychiatr. Epidemiol. 1995; 30(5):213–219
   PubMed Web of Science ®Google Scholar
• Murray, CJ and Lopez AD :Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 5-17-1997; 349(9063):1436–1442
   Google Scholar
• Rucci P, Frank E, Kostelnik B, Fagiolini A, Malinger AG, Swartz HA, Thase ME, Siegel L, Wilson D, and Kupfer DJ, Suicide attempts in patients with bipolar I disorder during acute and maintenance phases of intensive treatment with pharmacotherapy and adjunctive psychotherapy. Am. Psychiatry 2002; 159(7): 1160–1164
   Google Scholar
• Peele, PB, Xu Y, and Kupfer DJ :Insurance expenditures on bipolar disorder: clinical and parity implications. Am.Psychiatry2003; 160(7):1286–1290
   PubMed Web of Science ®Google Scholar
• Osby U Brandt L, Correia N, Ekbom A, and Sparen P :Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 2001; 58(9) : 844–850
   Google Scholar
• American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 Suppl 1:S5–S10
   Google Scholar
• Musselman DL, Betan E, Larsen H, and Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol. Psychiatry 8-1-2003; 54(3 ) :317–329
   Google Scholar
• Angst F, Stassen HH, Clayton PJ., and Angst J :Mortality of Patients with mood disorders: follow-up over 34–38 Years. J Affect. Disord. 2002; 68(2–3) : 167–181
   Google Scholar
• Keck PE, Buse JB, Dagogo-Jack S, D'Alessio DA, Daniels SR, McElroy SL, McIntyre RS, Sernyak MJ, Wirshing DA, and Wirshing, WC. Metabolic disease and severe mental illness. Post-graduate Medicine Special Report 2003
   Google Scholar
• Mukherjee S, Decina P. Bocola V. Saraceni F, and Scapicchio PL: Diabetes mellitus in schizophrenic patients. Compr. Psychiatry 1996; 37(1):68–73
   Google Scholar
• Goodnick PJ :Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann. Clin. Psychiatry 2001; 13(1):31–41
   Google Scholar
• Kooy FH :Hyperglycemia in mental disorders. Brain 1919; 42:214–289
   Google Scholar
• Braceland FJ, Meduna, LJ, and Vaichulis, JA: Delayed action of insulin in schizophrenia. Am. Psychiatry 1945; 102:108–110
   Web of Science ®Google Scholar
• Mukherjee S, Schnur DB, and Reddy, R: Family history of type 2 diabetes in schizophrenic patients. Lancet 3-4-1989;1(8636):495
   Google Scholar
• Okamura F, Tashiro A, Utumi A, Imai T, Suchi T, Tamura D, Sato Y, Suzuki S, and Hongo M: Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000; 49(10):1255–1260
   Google Scholar
• McIntyre RS, Mancini DA, and Basile VS: Mechanisms of antip-sychotic-induced weight gain. I Clin. Psychiatry 2001; 62(Suppl 23):23–29
   PubMedGoogle Scholar
• Haupt DW. and Newcomer JW: Abnormalities in glucose regula-tion associated with mental illness and treatment. I Psychosom. Res. 2002; 53(4):925–933
   Google Scholar
• Newcomer JW, Haupt DW, Fucetola R, Melson, AK, Schweiger JA, Cooper BP, and Selke G: Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch. Gen. Psychiatry 2002; 59(4):337–345
   PubMed Web of Science ®Google Scholar
• Shiloah E, Witz S, Abramovitch Y, Cohen 0, Buchs A, Ramot Y, Weiss M, Unger A, and Rapoport MJ: Effect of acute psychotic stress in nondiabetic subjects on beta-cell function and insulin sensitivity. Diabetes Care 2003; 26(5):1462–1467
   PubMed Web of Science ®Google Scholar
• Ryan MC, Collins P, and Thakore JH: Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am.Psychiatry 2003; 160(2):284–289
   PubMed Web of Science ®Google Scholar
• Rasgon N and Jarvik L: Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol. A Biol. Sci. Med Sci. 2004; 59(2):178–183
   Google Scholar
• Bushe C and Holt R: Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. Br. I Psychiatry Suppl 2004; 47:S67–S71
   Google Scholar
• Gildea EF, McLean VL, and Man, EB: Oral and intravenous dex-trose tolerance curves of patients with manic-depressive psycho-sis. Arch. NeuroL Psychiat. 1943; 49:852–859
   Google Scholar
• Van der Velde CD and Gordon MW: manic-depressive illness, diabetes mellitus, and lithium carbonate. Arch. Gen. Psychiatry 1969; 21:478–485
   Google Scholar
• Lilliker SL: Prevalence of diabetes in a manic-depressive popula-tion. Compr. Psychiatry 1980; 21(4):270–275
   Google Scholar
• Lustman PJ, Griffith LS, Clouse RE, and Cryer PE: Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv. Merit. Dis. 1986; 174(12):736–742
   Google Scholar
• Cassidy F, Ahearn E, and Carroll BJ: Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am. Psychiatry 1999; 156(9):1417–1420
   PubMed Web of Science ®Google Scholar
• Newcomer JW, Craft S, Fucetola R, Moldin SO, Selke G, Paras L, and Miller R: Glucose-induced increase in memory performance in patients with schizophrenia. Schizophr. Bull. 1999; 25(2):321–335
   PubMed Web of Science ®Google Scholar
• Regenold WT, Kling MA, and Hauser P: Elevated sorbitol con-centration in the cerebrospinal fluid of patients with mood disor-ders. Psychoneuroendocrinology 2000; 25(6):593–606
   Google Scholar
• Hale PJ, Nattrass M, Silverman, SH, Sennit C, Perkins CM, Uden A, and Sundkvist G: Peripheral nerve concentrations of glucose, fruc-tose, sorbitol and myoinositol in diabetic and non-diabetic patients. Diabetologia 1987; 30(7):464–467
   Google Scholar
• Regenold WT, Thapar RK, Marano C, Gavimeni S, and Kondapa-vuluru PV: Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaf-fective disorders independent of psychotropic drug use. I Affect. Disord. 2002; 70(1):19–26
   PubMed Web of Science ®Google Scholar
• Ruzickova M, Slaney C, Garnham J, and Alda M: Clinical fea-tures of bipolar disorder with and without comorbid diabetes mel-litus. Can. J. Psychiatry 2003; 48(7):458–461
   PubMed Web of Science ®Google Scholar
• Kessing LV, Nilsson FM, Siersma V, and Andersen PK: Increased risk of developing diabetes in depressive and bipolar disorders? J. Psychiatr. Res. 2004; 38(4):395–402
   Google Scholar
• Nilsson FM, Kessing LV, and Bolwig TG: Increased risk of developing Parkinson's Disease for patients with major affec-tive disorder: a register study. Acta Psychiatr. Scand. 2001; 104(5):380–386
   Google Scholar
• Kessing LV and Nilsson FM: Increased risk of developing demen-tia in patients with major affective disorders compared to patients with other medical illnesses. J Affect. Disord. 2003; 73(3):261–269
   Google Scholar
• Silveri F, Brecciaroli D, Argentati F, and Cervini C: Serum levels of insulin in overweight patients with osteoarthritis of the knee. J Rheumatol. 1994; 21(10):1899–1902
   Google Scholar
• Sturmer T, Brenner H, Brenner RE, and Gunther KP: Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthri-tis. The Ulm Osteoarthritis Study. Scand. I RheumatoL 2001; 30(3):169–171
   PubMed Web of Science ®Google Scholar
• Dessein PH, Stanwix AE, and Joffe BI: Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: Acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res. 2002; 4(5):R5
   Google Scholar
• Elmslie IL, Silverstone if, Mann JI, Williams SM, and Romans SE: Prevalence of overweight and obesity in bipolar patients. Clin. Psychiatry 2000; 61(3):179–184
   PubMed Web of Science ®Google Scholar
• McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, and Nemeroff, CB: Are mood disorders and obesity related? A review for the mental health professional. I Clin. Psychiatry 2004; 65(5):634–651
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Nagai K, and Nakagawa H: Additional evidence that the suprachiasmatic nucleus is the center for regulation of insulin secretion and glucose homeostasis. Brain Res. 6-25-1984; 304(2):237–241
   Google Scholar
• Ibuka N and Kawamura H: Loss of circadian rhythm in sleep-wakefulness cycle in the rat by suprachiasmatic nucleus lesions. Brain Res. 1975; 96(1):76–81
   Google Scholar
• Reppert SM and Weaver DR: Coordination of circadian timing in mammals. Nature 8-29-2002; 418(6901):935–941
   Google Scholar
• Berson DM: Strange vision: Ganglion cells as circadian photore-ceptors. Trends Neurosci. 2003; 26(6):314–320
   Google Scholar
• Nagai K, Fujii T, Inoue S, Takamura Y, and Nakagawa H: Electrical stimulation of the suprachiasmatic nucleus of the hypothalamus causes hyperglycemia. Horm. Metab Res 1988; 20(1):37–39
   PubMedGoogle Scholar
• Creager MA, Luscher TF, Cosentino F, and Beckman JA: Diabetes and vascular disease: pathophysiology, clinical con-sequences, and medical therapy: Part I. Circulation 9-23-2003; 108(12):1527–1532
   Google Scholar
• Luscher TF, Creager MA, Beckman JA, and Cosentino F: Diabe-tes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 9-30-2003; 108(13):1655–1661
   Google Scholar
• Ferguson SC, Blane A, Perros P. McCrimmon RI, Best JJ, Wardlaw J, Deary U, and Frier BM: Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and pre-ceding severe hypoglycemia. Diabetes 2003; 52(1):149–156
   Google Scholar
• Brands AM, Kessels RP, de Haan EH, Kappelle LJ, and Biessels GJ: Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur. I Pharmacol. 4-19-2004; 490(1–3):159-168
   Google Scholar
• Ahearn EP, Steffens DC, Cassidy F, Van Meter SA, Provenzale JM, Seldin MF, Weisler RH, and Krishnan KR: Familial Leu-koencephalopathy in bipolar disorder. Am. I Psychiatry 1998; 155(11):1605–1607
   Google Scholar
• Bearden CE, Hoffman KM, and Cannon TD: The neuropsychol-ogy and neuroanatomy of bipolar affective disorder: a critical review. Bipolar. Disord. 2001; 3(3):106–150
   PubMed Web of Science ®Google Scholar
• Moore PB, Shepherd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, and Ferrier IN: Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br. J. Psychiatry 2001; 178:172–176
   PubMed Web of Science ®Google Scholar
• Ziedonis D, Williams JM, and Smelson D: Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am. J Med Sci. 2003; 326(4):223–230
   PubMed Web of Science ®Google Scholar
• Watson S, Gallagher P, Ritchie JC, Ferrier IN, and Young AH: Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br. I Psychiatry 2004; 184:496–502
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. and Twardowska K: The dexamethasone/corti-cotropin-releasing hormone test in depression in bipolar and uni-polar affective illness../. Psychiatr. Res. 1999; 33(5):363–370
   Google Scholar
• Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, and Heuser U: Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depres-sion, and in normal controls: I. Biol. Psychiatry 12-15-1995; 38(12):797–802
   Google Scholar
• Dantzer R: Cytokine-induced sickness behavior: where do we stand? Brain Behav. Immun. 2001; 15(1):7–24
   Google Scholar
• Kronfol Z: Immune dysregulation in major depression: a critical review of existing evidence. Int. J. Neuropsychopharmacol. 2002; 5(4):333–343
   Google Scholar
• Hornig M, Goodman DB, Kamoun M, and Amsterdam JD: Posi-tive and negative acute phase proteins in affective subtypes. J Affect. Disord. 1998; 49(1):9–18
   PubMed Web of Science ®Google Scholar
• Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, and Leu SJ: Immunologic variables in acute mania of bipolar disorder. I Neu-roimmunol. 2004; 150(1-2):116–122
   Google Scholar
• Maes M, Bosmans E, Calabrese J, Smith R, and Meltzer HY: Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. I Psychiatr. Res. 1995; 29(2):141–152
   PubMed Web of Science ®Google Scholar
• Tsai SY, Chen KP, Yang YY, Chen CC, Lee JC, Singh VK, and Leu SJ: Activation of indices of cell-mediated immunity in bipo-lar mania. Biol. Psychiatry 4-15-1999; 45(8):989–994
   Google Scholar
• Tsai SY, Yang YY, Kuo CT, Chen CC, and Leu SJ: Effects of symptomatic severity on elevation of plasma soluble interleu-kin-2 receptor in bipolar mania. J Affect. Disord. 2001; 64(2-3): 185–193
   PubMed Web of Science ®Google Scholar
• Breunis MN, Kupka RW, Nolen WA, Suppes T, Denicoff KD, Leverich GS, Post RM, and Drexhage HA: High numbers of cir-culating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biol. Psychiatry 1-15-2003; 53(2):157–165
   Google Scholar
• Greenberg AS and McDaniel ML: Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabe-tes. European Journal of Clinical Investigation 2002; 32\(Suppl. 3): 24–34
   Google Scholar
• Grimble RF: Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab Care 2002; 5(5):551–559
   Google Scholar
• Pickup JC and Crook MA: Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41(10): 1241–1248
   PubMed Web of Science ®Google Scholar
• Donath MY, Storting J, Maecller K, and Mandrup-Poulsen T: Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. I Mol. Med. 2003; 81(8):455–470
   PubMed Web of Science ®Google Scholar
• Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, and Hainque B: Adipose tissue IL-6 content correlates with resistance to insulin activation of glu-cose uptake both in vivo and in vitro. I Clin. Endocrinol. Metab 2002; 87(5):2084–2089
   PubMed Web of Science ®Google Scholar
• Kern PA, Ranganathan S, Li C, Wood L, and Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. I Physiol Endo-crinol. Metab 2001; 280(5):E745–E751
   Web of Science ®Google Scholar
• Sadeghi HM, Schnelle IF, Thoma TK, Nishanian P. and Fahey IL: Phenotypic and functional characteristics of circulating mono-cytes of elderly persons. Exp. Gerontol. 1999; 34(8):959–970
   Google Scholar
• Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, and De Benedictis G: Inflamm-aging. An evolution-ary perspective on immunosenescence. Ann. N Y. Acad. Sci. 2000; 908:244–254
   PubMed Web of Science ®Google Scholar
• Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, Carella C, Giugliano D, Varricchio M, and D'Onofrio F: Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am. I Physiol 1998; 275(2 Pt 1):E294–E299
   Google Scholar
• Stoll AL, Renshaw PF, Yurgelun-Todd DA, and Cohen BM: Neuroimaging in bipolar disorder: What have we learned? Biol. Psychiatry 9-15-2000; 48(6):505–517
   Google Scholar
• Duelli R and Kuschinsky W: Brain glucose transporters: relation-ship to local energy demand. News Physiol Sci. 2001; 16:71–76
   PubMedGoogle Scholar
• McEwen BS, Magarinos AM, and Reagan LP: Studies of hor-mone action in the hippocampal formation: possible relevance to depression and diabetes. I Psychosom. Res. 2002; 53(4):883–890
   PubMed Web of Science ®Google Scholar
• Wood IS and Trayhurn P: Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br. I Nutr. 2003; 89(1):3–9
   PubMed Web of Science ®Google Scholar
• Garvey WT, Maianu L, Zhu TH, Brechtel-Hook G, Wallace P, and Baron AD: Evidence for defects in the trafficking and transloca-tion of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. I Clin. Invest 6-1-1998; 101(11):2377–2386
   Google Scholar
• Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Tra-janoski Z, Inzucchi S, Dresner A, Rothman DL, and Shulman GI: Impaired glucose transport as a cause of decreased insulin-stimu-lated muscle glycogen synthesis in type 2 diabetes. N. Engl. Med. 7-22-1999; 341(4):240–246
   Google Scholar
• Shepherd PR and Kahn BB: Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N .Engl. I Med. 7-22-1999; 341(4):248–257
   Google Scholar
• Gould TD, Zarate CA, and Manji HK: Glycogen synthase kinase-3: a target for novel bipolar disorder treatments. I Clin. Psychiatry 2004; 65(1):10–21
   PubMed Web of Science ®Google Scholar
• Cohrn P. and Frame S: The renaissance of GSK3. Nat Rev Mol Cell Biol 2001; 2(10):769–776
   Google Scholar
• Lenox RH, Gould TD, and Manji HK: Endophenotypes in bipo-lar disorder. Am. J Med. Genet. 5-8-2002; 114(4):391–406
   Google Scholar
• Horrobin DF and Bennett CN: Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormal-ities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot. Essent. Fatty Acids 1999; 60(4): 217–234
   Google Scholar
• Rapoport SI and Bosetti F: Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch. Gen. Psychiatry 2002; 59(7):592–596
   PubMedGoogle Scholar
• Florez JC, Hirschhorn J, and Altshuler D: The inherited basis of dia-betes mellitus: implications for the genetic analysis of complex traits. Annu. Rev. Genomics Hum. Genet. 2003; 4:257–291
   PubMedGoogle Scholar
• Baron M: Manic-depression genes and the new millennium: poised for discovery. Mol. Psychiatry 2002; 7(4):342–358
   Google Scholar
• Craddock N, Dave S, and Greening J: Association studies of bipolar disorder. Bipolar. Disord. 2001; 3(6):284–298
   PubMed Web of Science ®Google Scholar
• Chiba M, Suzuki S, Hinokio Y, Hirai M, Satoh Y, Tashiro A, Utsumi A, Awata T, Hongo M, and Toyota T: Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 2000; 49(9):1145–1149
   Google Scholar
• Cryns K, Sivakumaran TA, Van den Ouweland TM, Pennings, RI, Cremers CW, Flothmann K, Young TL, Smith RT, Lesperance MM, and Van Camp G: Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum. Mutat. 2003; 22(4):275–287
   PubMed Web of Science ®Google Scholar
• Swift M and Swift RG: Psychiatric disorders and mutations at the Wolfram syndrome locus. Biol. Psychiatry 5-1-2000; 47(9):787–793
   Google Scholar
• Kawamoto T, Horikawa Y, Tanaka T, Kabe N, Takeda J, and Milcuni M: Genetic variations in the WFS1 gene in Japanese with type 2 diabetes and bipolar disorder. Mol. Genet. Metab 2004; 82(3):238–245
   Google Scholar
• Reaven GM: Banting Lecture 1988. Role of Insulin resistance in human disease. Diabetes 1988; 37(12):1595–1607
   PubMed Web of Science ®Google Scholar
• Kato MM, Currier MB, Gomez CM, Hall L, and Gonzalez-Blanco M: Prevalence of metabolic syndrome in Hispanic and non-Hispanic patients with schizophrenia. Prim. Care Compan-ion. J Clin. Psychiatry 2004; 6(2):74–77
   Google Scholar
• American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27 Suppl 1:S11—S14
   Web of Science ®Google Scholar
• Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, and Baldessarini RJ: Risk of recurrence of bipolar disorder in preg-nant and nonpregnant women after discontinuing lithium main-tenance. Am. I Psychiatry 2000; 157(2):179–184
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, and Altshuler L: Management of Bipolar disorder during pregnancy and the post-partum period. Am. I Psychiatry 2004; 161(4):608–620
   PubMed Web of Science ®Google Scholar